Patents by Inventor Patrick Franchini

Patrick Franchini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240409990
    Abstract: The present invention relates to quality assurance methods for use in amplification techniques. such as Next Generation Sequencing (NGS).
    Type: Application
    Filed: February 14, 2024
    Publication date: December 12, 2024
    Applicant: PACBRIDGE PARTNERS II INVESTMENT CO., LTD.
    Inventors: Samuel APARICIO, Sohrab SHAH, Rosalia AGUIRRE-HERNANDEZ, Leah PRENTICE, Patrick FRANCHINI, Jaswinder Singh KHATTRA, Tong HE
  • Publication number: 20210155980
    Abstract: The present invention relates to quality assurance methods for use in amplification techniques, such as Next Generation Sequencing (NGS).
    Type: Application
    Filed: January 21, 2021
    Publication date: May 27, 2021
    Inventors: Samuel APARICIO, Sohrab SHAH, Rosalia AGUIRRE-HERNANDEZ, Leah PRENTICE, Patrick FRANCHINI, Jaswinder Singh KHATTRA, Tong HE
  • Patent number: 10934580
    Abstract: The present invention relates to quality assurance methods for use in amplification techniques, such as Next Generation Sequencing (NGS).
    Type: Grant
    Filed: September 23, 2016
    Date of Patent: March 2, 2021
    Assignee: CANEXIA HEALTH INC.
    Inventors: Samuel Aparicio, Sohrab Shah, Rosalia Aguirre-Hernandez, Leah Prentice, Patrick Franchini, Jaswinder Singh Khattra, Tong He
  • Publication number: 20180258479
    Abstract: The present invention relates to quality assurance methods for use in amplification techniques, such as Next Generation Sequencing (NGS).
    Type: Application
    Filed: September 23, 2016
    Publication date: September 13, 2018
    Inventors: Samuel APARICIO, Sohrab SHAH, Rosalia AGUIRRE-HERNANDEZ, Leah PRENTICE, Patrick FRANCHINI, Jaswinder Singh KHATTRA, Tong HE
  • Publication number: 20070166711
    Abstract: Polynucleotide and polypeptide sequences for HFE2A, as well as mutations associated with juvenile hemochromatosis, and methods of utilizing these for the screening and identification of agents for the treatment of diseases of iron metabolism, including small organic compounds, are disclosed along with methods of treating and/or ameliorating diseases of iron metabolism, especially in human patients are disclosed. Diagnostic compounds, kits and methods using HFE2A are also described.
    Type: Application
    Filed: April 8, 2004
    Publication date: July 19, 2007
    Inventors: Mark Samuels, Erwin Ludwig, Marcia MacDonald, Patrick Franchini, Yigal Goldberg, Rajender Kamboj, George Papanikolaou